CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-16 | Senner Christopher J. EVP and CFO | Option exercise | +100,000 | $18.80 | $1.9M | 1,067,842 |
| 2025-05-16 | Senner Christopher J. EVP and CFO | Sale | −100,000 | $46.00 | $4.6M | 967,842 |
| 2025-05-16 | Senner Christopher J. EVP and CFO | Option exercise · Option (right to buy) | −100,000 | 0 | ||
| 2025-05-16 | MORRISSEY MICHAEL President and CEO | Gift | −87,871 | 1,518,240 | ||
| 2025-05-16 | MORRISSEY MICHAEL President and CEO | Gift | +87,871 | 1,852,856 | ||
| 2025-05-16 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Option exercise | +40,000 | $21.75 | $870K | 538,169 |
| 2025-05-16 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Sale | −72,776 | $45.47 | $3.3M | 465,393 |
| 2025-05-16 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Option exercise · Option (right to buy) | −40,000 | 120,000 | ||
| 2025-05-15 | Aftab Dana CSO/EVP Disc & Trans Research | Shares withheld for taxes | −30,693 | $44.65 | $1.4M | 662,488 |
| 2025-05-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −41,422 | $44.65 | $1.8M | 967,842 |
| 2025-05-15 | PAPADOPOULOS STELIOS Director | Option exercise | +20,634 | $19.77 | $408K | 1,300,050 |
| 2025-05-15 | PAPADOPOULOS STELIOS Director | Sale | −20,634 | $44.35 | $915K | 1,279,416 |
| 2025-05-15 | PAPADOPOULOS STELIOS Director | Option exercise | +15,874 | $20.50 | $325K | 1,295,290 |
| 2025-05-15 | PAPADOPOULOS STELIOS Director | Sale | −15,874 | $44.35 | $704K | 1,279,416 |
| 2025-05-15 | PAPADOPOULOS STELIOS Director | Option exercise · Option (right to buy) | −20,634 | 0 | ||
| 2025-05-15 | PAPADOPOULOS STELIOS Director | Option exercise · Option (right to buy) | −15,874 | 0 | ||
| 2025-05-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −104,769 | $44.65 | $4.7M | 1,606,111 |
| 2025-05-15 | Hessekiel Jeffrey EVP & General Counsel | Shares withheld for taxes | −34,035 | $44.65 | $1.5M | 718,396 |
| 2025-05-15 | Hessekiel Jeffrey EVP & General Counsel | Sale | −25,000 | $46.18 | $1.2M | 693,396 |
| 2025-05-15 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes 10b5-1 | −34,705 | $44.65 | $1.5M | 456,459 |
Page 7 of 10 · 192 trades